To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Advent Ventures forms company for pharmaceutical acquisitions
Advent Venture Partners, a European venture capital firm, has formed a new company to acquire speciality pharmaceutical prescription products, headed by former Roche, Elan and Xenova veteran Geoff McMillan.
